We are live on ! Find out more
MCM

Matarin Capital Management Portfolio holdings

AUM $409M
1-Year Est. Return 33.03%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
AUM
$1.28B
AUM Growth
+$108M
Cap. Flow
+$48.1M
Cap. Flow %
3.75%
Top 10 Hldgs %
12.71%
Holding
333
New
42
Increased
153
Reduced
75
Closed
42

Sector Composition

Rank Sector Weight
1 Financials 17.22%
2 Industrials 15.31%
3 Consumer Discretionary 12.43%
4 Technology 12.29%
5 Healthcare 10.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PERY
151
DELISTED
Perry Ellis International Inc
PERY
$2.83M 0.22%
113,116
+18,677
+20% +$445K
UNM icon
152
Unum
UNM
$14B
$2.8M 0.22%
50,977
+3,530
+7% +$189K
CELG
153
DELISTED
Celgene Corp
CELG
$2.78M 0.22%
26,628
-5,491
-17% -$620K
EBSB
154
DELISTED
Meridian Bancorp, Inc.
EBSB
$2.73M 0.21%
132,359
+20,057
+18% +$396K
HTO
155
H2O America
HTO
$2.76B
$2.71M 0.21%
+42,400
New +$2.68M
MSFT icon
156
Microsoft
MSFT
$2.96T
$2.69M 0.21%
31,397
+5,726
+22% +$470K
ESND
157
DELISTED
Essendant Inc.
ESND
$2.67M 0.21%
288,066
+24,892
+9% +$256K
ALGN icon
158
Align Technology
ALGN
$12.5B
$2.66M 0.21%
11,975
+216
+2% +$49.1K
SYY icon
159
Sysco
SYY
$41B
$2.65M 0.21%
43,697
-5,005
-10% -$284K
RM icon
160
Regional Management Corp
RM
$390M
$2.44M 0.19%
92,827
-36,495
-28% -$893K
CNR
161
Core Natural Resources Inc
CNR
$4.01B
$2.4M 0.19%
+60,791
New +$1.77M
CLS icon
162
Celestica
CLS
$38.9B
$2.39M 0.19%
228,259
-2,432
-1% -$26.9K
NSP icon
163
Insperity
NSP
$2.01B
$2.38M 0.19%
41,541
+35,841
+629% +$1.9M
KFRC icon
164
Kforce
KFRC
$1.06B
$2.38M 0.19%
94,151
-57,520
-38% -$1.35M
UFCS icon
165
United Fire Group
UFCS
$1.34B
$2.31M 0.18%
+50,692
New +$2.37M
AAWW
166
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$2.3M 0.18%
39,278
-153,725
-80% -$9.17M
MNTA
167
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.23M 0.17%
159,527
-79,183
-33% -$1.07M
BSTC
168
DELISTED
BioSpecifics Technologies Corp.
BSTC
$2.12M 0.17%
48,952
-10,125
-17% -$455K
SYKE
169
DELISTED
SYKES Enterprises Inc
SYKE
$2.1M 0.16%
66,800
+11,136
+20% +$336K
ACOR
170
DELISTED
Acorda Therapeutics
ACOR
$1.95M 0.15%
+756
New +$2.15M
ERF
171
DELISTED
Enerplus Corporation
ERF
$1.91M 0.15%
194,611
-6,355
-3% -$58K
CNXN icon
172
PC Connection
CNXN
$2.1B
$1.9M 0.15%
72,542
+44,376
+158% +$1.2M
FSLR icon
173
First Solar
FSLR
$21.6B
$1.9M 0.15%
+28,145
New +$1.65M
FRAN
174
DELISTED
Francesca's Holdings Corporation
FRAN
$1.9M 0.15%
21,649
+7,489
+53% +$629K
COP icon
175
ConocoPhillips
COP
$139B
$1.89M 0.15%
34,419

Similar funds

Matarin Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Matarin Capital Management held 333 positions worth $1.28B, up 9.2% from $1.18B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Matarin Capital Management deployed $48.1M of net new capital in Q4 2017, opening 42 new positions and adding to 153 existing holdings. Its largest new stake was Hyster-Yale Materials Handling: 99,902 shares worth $8.51M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Atlas Air Worldwide Holdings, Inc., an estimated $9.17M trimmed.

  • Matarin Capital Management's largest Q4 2017 buy was Hyster-Yale Materials Handling: 99,902 shares worth $8.51M.
  • Matarin Capital Management added most to Myriad Genetics in Q4 2017, an estimated $11.3M increase.
  • Matarin Capital Management's biggest Q4 2017 reduction was Atlas Air Worldwide Holdings, Inc., cutting an estimated $9.17M.
  • Matarin Capital Management fully exited Sabra Healthcare REIT in Q4 2017, selling an estimated $9.24M.
  • Matarin Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q4 2017.
  • Matarin Capital Management opened 42 new positions and closed 42 in Q4 2017.
  • Matarin Capital Management's portfolio value rose 9.2% quarter-over-quarter to $1.28B.

Based on Matarin Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.